Viriom Inc

Innovative Treatments for HIV and Chronic HBV Infections Worldwide

General Information
Company Name
Viriom Inc
Founded Year
2009
Location (Offices)
San Diego, United States +1
Founders / Decision Makers
Number of Employees
9
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Convertible Note
Social Media

Viriom Inc - Company Profile

Viriom Inc. is a biotech firm founded in 2009 with a focus on developing innovative and affordable medications for life-threatening infections such as HIV and HBV. The company holds an exclusive global license from Hoffmann-La Roche and its lead compounds - Elpida/elsulfavirine and VM1500A - are in advanced phases. In addition, Viriom has proprietary drug candidates VM2500 and VM3500 LAI formulations, as well as combinations involving cell, vaccine, and antibody drugs aimed at treating, preventing, and curing HIV and chronic HBV infections worldwide. The last investment round, a $12.50M Convertible Note investment from Pharmstandard, took place on 06 December 2017. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy: biotech firm, medications, HIV, HBV, global license, drug development, commercial stage, novel medicines, infections, treatment, prevention, cure, proprietary drug candidates, phase 3, Hoffmann-La Roche

Funding Rounds & Investors of Viriom Inc (8)

View All
Funding Stage Amount No. Investors Investors Date
Convertible Note $12.50M 1 Pharmstandard 06 Dec 2017
Convertible Note $2.56M 1 06 Jun 2017
Convertible Note $2.35M 3 ChemRar Ltd 11 May 2016
Convertible Note $3.00M 1 01 Sep 2015
Seed Round $5.00M 2 MIT RF, ChemRar Ventures 01 Dec 2012

View All 8 Funding Rounds

Latest News of Viriom Inc

View All

No recent news or press coverage available for Viriom Inc.

Similar Companies to Viriom Inc

View All
NASTAD - Similar company to Viriom Inc
NASTAD NASTAD's vision is a world committed to ending HIV/AIDS, viral hepatitis, and intersecting epidemics.
Idenix Pharmaceuticals - Similar company to Viriom Inc
Idenix Pharmaceuticals Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a strong presence in the U.S. and Europe.
Replicor Inc. - Similar company to Viriom Inc
Replicor Inc. 292 million people have chronic hepatitis B. We're developing the cure.
Novira Therapeutics - Similar company to Viriom Inc
Novira Therapeutics Discovering & developing novel antivirals. Novira was founded by Dr. Ali H. Munawar in 2008 and acquired by J&J in 2015